期刊文献+

葡萄糖调节蛋白-78在肝癌组织中的表达及其意义分析

Expression and significance of glucose regulatory protein-78 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨葡萄糖调节蛋白-78(GRP-78)在肝细胞癌(HCC)组织中的表达情况及其对肝癌细胞增殖的影响。方法统计83例肝癌患者的HCC组织、癌旁组织及正常肝组织中GRP-78的阳性表达率。测定不同肝癌细胞系中GRP-78mRNA的相对表达水平,将表达水平最高的肝癌细胞系进行扩增培养。将扩增后的细胞分为未转染的空白组、小干扰RNA(siRNA)-NC组及GRP-78-siRNA组,分析3组细胞的增殖抑制率、凋亡率及磷脂酰肌醇3激酶(PI3K)/丝苏氨酸蛋白激酶(AKT)信号通路中相关蛋白的表达水平。结果3种组织中HCC组织中GRP-78的阳性表达率最高(P<0.05),且与HCC患者的TNM分期呈正相关(P<0.05);在SMMC-7721肝癌细胞系中,GRP-78mRNA的相对表达水平最高;在干扰48h及72h时,GRP-78-siRNA组的细胞抑制率显著高于空白组及siRNA-NC组,差异有统计学意义(P<0.05);而在干扰48h时,GRP-78-siRNA组的细胞凋亡率高于另外两组,差异有统计学意义(P<0.05);与空白组、siRNA-NC组比较,GRP-78-siRNA组的E-cadherin表达升高,vimentin、磷酸化-PI3K(p-PI3K)、磷酸化-AKT(p-AKT)表达降低,组间差异有统计学意义(P<0.05)。结论GRP-78可通过PI3K/AKT信号通路促进肝癌的发生。 Objective To investigate the expression of glucose-regulated protein-78(GRP-78)in hepatocellular carcinoma(HCC)and its effect on the proliferation of liver cancer.Methods The positive expression rate of GRP-78 in HCC tissues,adjacent tissues and normal liver tissues of 83 patients with HCC was analyzed.The relative expression of GRP-78 mRNA in different liver cancer cell lines was measured,and the liver cancer cell line with the highest expression level of GRP-78 were amplified and cultured.The amplified cells were divided into the blank group,the siRNA-NC group and the GRP-78-siRNA group,and the proliferation inhibition rate,apoptosis rate and expression level of related proteins in the PI3 K/AKT signaling pathway were analyzed in the three groups.Results The positive expression rate of GRP-78 in HCC tissues was the highest(P<0.05),and it was positively correlated with TNM stage of HCC patients(P<0.05).The expression of GRP-78 mRNA was the highest in SMMC-7721 cell line.At 48 hand 72 h,the cell inhibition rate of the GRP-78-siRNA group was significantly higher than that of the blank group and the siRNA-NC group(P<0.05).At 48 h,the apoptosis rate of the GRP-78-siRNA group was higher than that of the other two groups(P<0.05).Compared with the blank group and the siRNA-NC group,the expression level of E-cadherin in the GRP-78-siRNA group was increased,while the expression levels of vimentin,p-P13 Kand p-AKT were downregulated,the differences were statistically significant(P<0.05).Conclusion GRP-78 can promote the development of liver cancer through PI3 K/AKT signaling pathway.
作者 马颖 马玲 马明 MA Ying;MA Ling;MA Ming(Medical Laboratory Center,the First Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang 830054,China;Department of Pharmacy,Chest Hospital of Xinjiang Uygur Autonomous Region,Urumqi,Xinjiang 830001,China;Department of Hepatobiliary Surgery,People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi,Xinjiang 830054,China)
出处 《重庆医学》 CAS 2021年第6期917-921,共5页 Chongqing medicine
基金 新疆维吾尔自治区自然科学基金(2018D01C186)。
关键词 葡萄糖调节蛋白-78 肝肿瘤 细胞凋亡 PI3K/AKT通路 glucose regulatory protein-78 liver neoplasms cell apoptosis PI3K/AKT signaling pathway
  • 相关文献

参考文献2

二级参考文献56

  • 1吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 2Koh C, Zhao X, Samala N, et al. AASLD clinical practice guide- lines: a critical review of scientific evidence and evolving reco- mmendations[J]. Hepatology, 2013, 58(6): 2142-2152.
  • 3William H, Ralph H, Timothy H, et al. Surgical pathology dissec- tion: an illustrated guide[ M]. New York:Springer, 2003:7-9.
  • 4Bass BP, Engel KB, Greytak SR, et al. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin- embedded ( FFPE ) tissue : how well do you know your FFPE specimen? [ J]. Arch Pathol Lab Med, 2014, 138(11): 1520-1530.
  • 5Lu XY, Xi T, Lau WY, et al. Hepatoeellular carcinoma expres- sing cholangiocyte phenotype is a novel subtype with highly aggressive behavior [ J ]. Ann Surg Oncol, 2011, 18 ( 8 ) : 2210-2217.
  • 6Cai SW, Yang SZ, Gao J, et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adeno- carcinoma[ J ]. Surgery, 201 l, 149 (4) : 576-584.
  • 7应越英.肝细胞肝癌的病理学//汤钊猷,主编.原发性肝癌[M].上海:上海科学技术出版社,1981:115-146.
  • 8Nakanuma Y, Curado MP, Franceschi S, et al. Intrahepatic cholangiocarcinoma//Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System[M]. 4th ed. Lyon:IARC Press, 2010: 217-227.
  • 9Cong WM, Wu MC. Small hepatocellular carcinoma: current and future approaches[J]. Hepatol Int, 2013, 7(3) : 805-812.
  • 10Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and bio- logical behavior[J]. J Cancer Res Clin Oncol, 2011, 137 (4): 567-575.

共引文献328

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部